Severe Acute Respiratory Syndrome: all 386 studies

Page 1 of 4. Open to participants first (14), then studies with results posted, then the rest; newest registration first within each.

• Clinical Multimodal Surveillance of Respiratory Syndrome PathogensRecruitingNCT07694648
• Bio-Manguinhos/Fiocruz COVID-19 (mRNA) Vaccine BoosterNot yet recruitingNCT07640308Phase 1
• Steroid Treatment for Severe Acute Respiratory Infection (STAR) TrialNot yet recruitingNCT07199192Phase 4
• Extracellular Vesicles From Mesenchymal Cells in the Treatment of Acute Respiratory FailureNot yet recruitingNCT06002841Phase 1/2
• A Clinical Evaluation of the Safety and Efficacy of Randomized Placebo Versus the 8-aminoquinoline Tafenoquine for Early Symptom Resolution in Patients With Mild to Moderate COVID 19 Disease and Low Risk of Disease ProgressionNot yet recruitingNCT05947812Phase 2
• Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental OxygenRecruitingNCT05624450Phase 3
• NAC for Attenuation of COVID-19 SymptomatologyNot yet recruitingNCT05074121Phase 2
• Imaging Immune Activation in COVID-19RecruitingNCT04815096Phase 2
• Repurposed Approved and Under Development Therapies for Patients With Early-Onset COVID-19 and Mild SymptomsRecruitingNCT04727424Phase 3
• KIDney Injury in Times of COVID-19 (KIDCOV)Enrolling by invitationNCT04705766
• Infection Tracking in Travellers. The Project Aims to Identify Profiles of Travel-associated Illness and to Follow up on Long-term Sequelae of Arboviral Infections and MalariaNot yet recruitingNCT04672577
• Expanded Access to Zofin for Patients With COVID-19AvailableNCT04657406
• Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA StudyRecruitingNCT04579471
• Outcomes Mandate National Integration With Cannabis as MedicineRecruitingNCT03944447Phase 2
• A US Study to Look at Loss of Work and Healthcare Costs for People Affected With Mild-to-moderate COVID 19 Who Have High Chances of the Disease Becoming SevereCompletedNCT07072793Results posted
• Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)CompletedNCT06729606Phase 3Results posted
• Remdesivir for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)CompletedNCT06729593Phase 3Results posted
• A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled MBS-COV (SNS812) in Healthy ParticipantsCompletedNCT05677893Phase 1Results posted
• SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19CompletedNCT05629962Phase 3Results posted
• Study of Varespladib in Patients Hospitalized With Severe COVID-19TerminatedNCT04969991Phase 2Results posted
• Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination VaccineCompletedNCT04961541Phase 1/2Results posted
• SARS-CoV-2 Human Challenge Characterisation StudyCompletedNCT04865237Not applicableResults posted
• COVID-19: A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARS-CoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbiditiesTerminatedNCT04860258Phase 3Results posted
• A Study to Evaluate the Safety and Efficacy of C19-IG 20% in SARS-CoV-2 Infected Asymptomatic Ambulatory OutpatientsTerminatedNCT04847141Phase 3Results posted
• ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19CompletedNCT04843761Phase 3Results posted
• VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on StudyCompletedNCT04842747Phase 3Results posted
• Safety and Tolerability of COVID-19 Vaccine (ABNCoV2)CompletedNCT04839146Phase 1Results posted
• COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 VaccinationsCompletedNCT04761822Phase 2Results posted
• Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19CompletedNCT04732949Phase 3Results posted
• Proxalutamide Treatment for Hospitalized COVID-19 PatientsCompletedNCT04728802Phase 3Results posted
• A Study of TAK-019 in Healthy Japanese Adults (COVID-19)CompletedNCT04712110Phase 1/2Results posted
• Sargramostim Use in COVID-19 to Recover Patient HealthCompletedNCT04707664Phase 2Results posted
• A Study to Evaluate the Safety and Immunogenicity of Vaccine CVnCoV in Healthy Adults in Germany for COVID-19CompletedNCT04674189Phase 3Results posted
• A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy AdultsTerminatedNCT04668339Phase 2Results posted
• Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19)TerminatedNCT04664075Results posted
• Camostat With Bicalutamide for COVID-19TerminatedNCT04652765Phase 1Results posted
• Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 ExposureTerminatedNCT04642638Phase 2/3Results posted
• A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19TerminatedNCT04605588Phase 2Results posted
• GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19)CompletedNCT04590547Phase 2Results posted
• Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)CompletedNCT04546581Phase 3Results posted
• COVID-FIS: Pilot in COVID-19 (SARS-CoV-2) of Fisetin in Older Adults in Nursing HomesTerminatedNCT04537299Phase 2Results posted
• A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19CompletedNCT04515147Phase 2Results posted
• COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19)CompletedNCT04510194Phase 3Results posted
• Camostat Mesilate Treating Patients With Hospitalized Patients With COVID-19CompletedNCT04470544Phase 2Results posted
• A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19CompletedNCT04449276Phase 1Results posted
• Anti-Androgen Treatment for COVID-19CompletedNCT04446429Not applicableResults posted
• ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS)TerminatedNCT04432272Phase 2Results posted
• Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of Covid 19CompletedNCT04425863Results posted
• Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19)TerminatedNCT04409873Phase 2Results posted
• LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)CompletedNCT04402957Phase 2Results posted
• A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19CompletedNCT04402060Phase 1/2Results posted
• COVID-19 and Anti-CD14 Treatment TrialTerminatedNCT04391309Phase 2Results posted
• Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory FailureTerminatedNCT04389840Phase 2/3Results posted
• COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111CompletedNCT04388826Phase 2Results posted
• Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory SymptomsTerminatedNCT04382391Not applicableResults posted
• Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19)CompletedNCT04380519Phase 2/3Results posted
• Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related DiseaseCompletedNCT04376684Phase 2Results posted
• Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary InjuryCompletedNCT04375397Phase 2Results posted
• Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19TerminatedNCT04365985Phase 2Results posted
• Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 InfectionCompletedNCT04357730Phase 2Results posted
• Convalescent Plasma in the Treatment of COVID 19CompletedNCT04343261Phase 2Results posted
• Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 InfectionCompletedNCT04340557Phase 4Results posted
• Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic DiseaseCompletedNCT04332991Phase 3Results posted
• Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP)CompletedNCT04328961Phase 2/3Results posted
• Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory SyndromeCompletedNCT04323592Results posted
• Losartan for Patients With COVID-19 Requiring HospitalizationCompletedNCT04312009Phase 2Results posted
• Losartan for Patients With COVID-19 Not Requiring HospitalizationCompletedNCT04311177Phase 2Results posted
• Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2CompletedNCT04308668Phase 3Results posted
• Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19CompletedNCT04306393Phase 2Results posted
• Saliva PCR in Pregnant Women with COVID-19CompletedNCT06735300
• Evaluation of KGR Prescriptions in Suppressing COVID-19 Infection.CompletedNCT06291883Phase 1
• Effect of Early Implementation of Prone PositioningCompletedNCT06287554
• Insulin Regulation and Severity of Severe Acute Respiratory Syndrome COVID-19 InfectionCompletedNCT05897528
• Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19CompletedNCT05886816Phase 2
• Early Diagnosis of Clinical Evolution From SARS-CoV-2CompletedNCT05787405
• Medicine-induced Cardiac Hemodialysis on COVID-19CompletedNCT05711810Phase 4
• A Clinical Trial to Study the COVAC-1 Booster Dose in Generally Healthy AdultsCompletedNCT05693272Phase 1
• Should Palatine Tonsils be Included in the Oropharyngeal Swab for SARS-CoV-2 Molecular Testing?Status unknownNCT05611203Not applicable
• Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901aCompletedNCT05548439Phase 1
• A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19WithdrawnNCT05545319Phase 2
• Antigen Rapid Diagnostic Tests for Community Identification of Severe Acute Respiratory Syndrome Coronavirus 2CompletedNCT05458557
• Value of Platelet-Rich Plasma in Post Severe Acute Respiratory Syndrome Coronavirus 2Status unknownNCT05395845Early Phase 1
• Fetal and Neonatal Thyroid in Pregnancies With Severe Acute Respiratory Syndrome Coronavirus 2 ( SARS- COV2 ) COVID-19CompletedNCT05385029
• How Future Surgery Will Benefit From Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Related Measures Perspective From Italian Young Surgeon Society (SPIGC)CompletedNCT05323851
• COVID-19 Vaccine Response in Chronic Respiratory ConditionsCompletedNCT05313087
• Phase 3 Boosting Study for the SARS-CoV-2 rS VaccineCompletedNCT05249816Phase 3
• The CHILD Cohort COVID-19 Add-On StudyCompletedNCT05234359
• Baromètre Santé Adulte 2021-2022SuspendedNCT05218304Not applicable
• A Clinical Trial of COVAC-2 in AdultsCompletedNCT05209009Phase 2
• Early-initiated High Flow Oxygen Therapy vs Conventional Oxygen Therapy Among Patients With ARDS in the Course of SARS-CoV2 Pneumonia.Status unknownNCT05197686Not applicable
• Clinical Performance Evaluation of the NeuMoDx™ FluA/FluB/RSV/Severe Acute Respiratory Syndrome-CoV-2 AssayCompletedNCT05162547
• A Clinical Trial of COVAC-1, a COVID-19 Vaccine, in Generally Healthy AdultsWithdrawnNCT05155982Phase 1
• Severe Acute Respiratory Syndrome CoV 2 COVID-19 Survey and Vaccination Coverage in the Sickle Cell Population in Ile-De-FranceStatus unknownNCT05153044Not applicable
• PEEP Setting in COVID19-related ARDSCompletedNCT05115526
• Plasma SARS-CoV-2 RNA Levels in Critically Ill COVID-19 PatientsCompletedNCT05115045
• A Clinical Evaluation of Pine Trees Health Test System Including the Pine Trees Health Reader and COVID-19 Test for Point-of-CareCompletedNCT05107258
• Follow-up of Covid-19 Long Term SequelaeCompletedNCT05097677
• Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Buccal Screening Evaluation Using an RT-PCR Assay and a Rapid ELISA Test Among Symptomatic and Asymptomatic PatientsStatus unknownNCT05074745Not applicable
• Index Individuals in SARS-CoV-2 Prevention Research Studies (COVID-19 Index Individuals Companion Study)CompletedNCT05074719
• SARS-CoV-2 (COVID-19) Antibody PrevalencE in an Adult London HIV CohortCompletedNCT05067400

← Severe Acute Respiratory Syndrome overview